Terms: = Colorectal cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68 AND Treatment
10 results:
1. Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of colorectal cancer at Distinct Stages of Progression.
Li L; Jiang D; Liu H; Guo C; Zhang Q; Li X; Chen X; Chen Z; Feng J; Tan S; Huang W; Huang J; Xu C; Liu CY; Yu W; Hou Y; Ding C
Cancer Res; 2024 Sep; 84(17):2888-2910. PubMed ID: 38861363
[TBL] [Abstract] [Full Text] [Related]
2. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
[No Abstract] [Full Text] [Related]
3. CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in colorectal cancer.
Zou S; Qin B; Yang Z; Wang W; Zhang J; Zhang Y; Meng M; Feng J; Xie Y; Fang L; Xiao L; Zhang P; Meng X; Choi HH; Wen W; Pan Q; Ghesquière B; Lan P; Lee MH; Fang L
Cancer Res; 2023 Feb; 83(3):414-427. PubMed ID: 36512632
[TBL] [Abstract] [Full Text] [Related]
4. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein ddx5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract] [Full Text] [Related]
5. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
[TBL] [Abstract] [Full Text] [Related]
6. Wnt/β-catenin signaling and p68 conjointly regulate CHIP in colorectal carcinoma.
Kal S; Chakraborty S; Karmakar S; Ghosh MK
Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119185. PubMed ID: 34890713
[TBL] [Abstract] [Full Text] [Related]
7. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11.
Xing S; Wang Y; Hu K; Wang F; Sun T; Li Q
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32812032
[TBL] [Abstract] [Full Text] [Related]
8. The Incidence of Low Anterior Resection Syndrome as Assessed in an International Randomized Controlled Trial (MRC/NIHR ROLARR).
Bolton WS; Chapman SJ; Corrigan N; Croft J; Collinson F; Brown JM; Jayne DG
Ann Surg; 2021 Dec; 274(6):e1223-e1229. PubMed ID: 32097165
[TBL] [Abstract] [Full Text] [Related]
9. High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
Tarella C; Cuttica A; Vitolo U; Liberati M; Di Nicola M; Cortelazzo S; Rosato R; Rosanelli C; Di Renzo N; Musso M; Pavone E; Santini G; Pescarollo A; De Crescenzo A; Federico M; Gallamini A; Pregno P; Romano R; Coser P; Gallo E; Boccadoro M; Barbui T; Pileri A; Gianni AM; Levis A
Cancer; 2003 Jun; 97(11):2748-59. PubMed ID: 12767087
[TBL] [Abstract] [Full Text] [Related]
10. Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours.
Zhou Y; Gobl A; Wang S; Jacobsen MB; Janson ET; Haines GK; Radosevich JA; Oberg K
Eur J Cancer; 1998 Dec; 34(13):2046-52. PubMed ID: 10070309
[TBL] [Abstract] [Full Text] [Related]
